Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.14%
1,102.18
+1.57
+0.14%
—1,100.611,106.151,114.281,098.89——
SIXC
Communications
SIXC
Communications
SIXC
+0.64%
616.24
+3.94
+0.64%
—612.30612.30616.40612.30——
SIXE
Energy
SIXE
Energy
SIXE
+1.21%
1,189.72
+14.26
+1.21%
—1,175.461,182.971,193.951,182.97——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.20%
1,725.69
-3.43
-0.20%
—1,729.121,731.371,754.071,718.58——
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
643.62
-1.11
-0.17%
—644.73645.31649.16642.15——
SIXR
Staples
SIXR
Staples
SIXR
+0.33%
829.79
+2.70
+0.33%
—827.09828.05833.90827.27——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.66%
213.40
-1.42
-0.66%
—214.82214.82216.61212.62——
SIXT
Technology
SIXT
Technology
SIXT
+2.27%
3,185.92
+70.75
+2.27%
—3,115.173,142.773,186.203,133.07——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.16%
908.94
-1.49
-0.16%
—910.43915.18923.94906.03——
SIXV
Health care
SIXV
Health care
SIXV
+0.30%
1,478.96
+4.46
+0.30%
—1,474.501,480.841,491.461,475.55——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.02%
2,405.36
-0.51
-0.02%
—2,405.872,415.572,420.792,398.99——
AVH:ASX
AVITA Medical Inc
A$1.32
-4.71%
(-0.065) 1D
Apr 22, 4:11:43 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for AVH...
Open
A$1.37
High
A$1.37
Low
A$1.31
Mkt. cap
203.35M
Avg. vol.
311.84K
Volume
371.59K
52-wk high
A$3.18
52-wk low
A$1.00
Shares outstanding
30.63M
No. of employees
226
News stories
From sources across the web
Profile
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees226
Founded1999
HeadquartersValencia, California, United States
SectorBiotechnology
Last report
Feb 12, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.54/ (-0.55 est.)AUD
+2.80%beat
Revenue / Estimate
24.84M/ (25.23M est.)AUD
-1.56%miss
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
18.51M
18.42M
17.06M
17.62M
Cost of goods sold
2.83M
3.47M
3.19M
3.30M
Cost of revenue
2.83M
3.47M
3.19M
3.30M
Research and development expenses
6.28M
5.12M
3.75M
5.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.22M
20.98M
19.28M
19.03M
Operating expense
27.51M
26.10M
23.03M
24.72M
Total operating expenses
30.34M
29.57M
26.22M
28.02M
Operating income
-11.83M
-11.15M
-9.15M
-10.41M
Other non operating income
-791.00K
3.38M
-2.15M
737.00K
EBT including unusual items
-13.85M
-9.92M
-13.17M
-11.64M
EBT excluding unusual items
-13.85M
-9.02M
-12.27M
-11.04M
Income tax expense
8.00K
4.00K
15.00K
-17.00K
Effective tax rate
-0.06%
-0.04%
-0.11%
0.15%
Other operating expenses
-
-
-
-
Net income
-13.86M
-9.92M
-13.19M
-11.62M
Net profit margin
-74.86%
-53.86%
-77.29%
-65.97%
Earnings per share
-
-
-
-
Interest and investment income
-
400.00
300.00K
200.00K
Interest expense
-1.23M
-1.25M
-1.27M
-1.55M
Net interest expenses
-1.23M
-1.25M
-970.20K
-1.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.31M
-10.60M
-8.58M
-9.76M
Gain or loss from assets sale
14.00K
335.00K
252.00K
5.00K
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more